Page 163 - Read Online
P. 163

Tian et al.                                                                                                                                                   EMT drives anti-estrogen resistance in breast cancer

































































           Figure 2: Induction of EMT programs by TGF-β promotes ER-α accumulation in the cytoplasm of MCF-7 cells. (A) MCF-7 cells were
           treated with either TGF-β1 (5 ng/mL), estradiol (1 nmol/L), or both agonists for 96 h as indicated. Afterward, the cells were fixed in
           paraformaldehyde and processed for indirect E-cad immunofluorescence. Images are representative of 3-independent experiments (×400).
           (B and C) MCF-7 cells were treated with TGF-β1 (5 ng/mL) in either 2D- (B) or 3D- (C) cultures for 0-96 h, at which point differences
           in ER-α expression were measured by real-time PCR. Data are the mean fold-changes (± SE; n = 3; *P < 0.05; Student’s t-test). (D)
           Differential mRNA expression of ER-α and ER-β in quiescent MCF-7 cells. Data are the mean (± SE; n = 3; *P < 0.05; Student’s t-test).
           (E) MCF-7 (top) and BT474 (bottom) cells were stimulated with TGF-β1 (5 ng/mL) for 0-96 h. Afterward, ER-α expression levels were
           monitored by immunoblotting. Images are representative of 4-independent experiments. (F) MCF-7 cells were transiently transfected
           overnight with either the pSBE- or pERE-luciferase reporter genes, as well as with the pCMV-β-galactosidase reporter gene to control for
           differences in transfection efficiency. Afterward, the transfectants were stimulated overnight either singly or in combination with TGF-β1
           (T; 5 ng/mL) or estradiol (E; 0.1 nmol/L) prior to measuring luciferase and β-gal activities. Data are the mean fold-changes (± SE; n = 3;
           *P < 0.05; Student’s t-test). (G) Pre- and post-EMT MCF-7 cells were transiently transfected overnight with pERE-luciferase and pCMV-β-
           gal-luciferase cDNAs, followed by 24 h treatment with either TGF-β1 (5 ng/mL) or estradiol (0.1 nmol/L). Data are the mean fold-changes
           (± SE; n = 3; *P < 0.05; Student’s t-test). (H) MCF-7 cells were treated with TGF-β1 (5 ng/mL) for 0-96 h, at which point the expression of
           ER-α in cytoplasmic and nuclear cell fractions was determined by immunoblotting. Stripped blots were reprobed with antibodies to either
           HDAC1 or β-actin to monitor integrity of nuclear and cytoplasmic fractions, respectively. Images are representative of at least 3-independent
           experiments. TGF: transforming growth factor; EMT: epithelial-mesenchymal transition; ER: estrogen receptor; SE: standard error
                           Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ August 21, 2017        155
   158   159   160   161   162   163   164   165   166   167   168